Genetic Cholesteryl Ester Transfer Protein Deficiency Is Extremely Frequent in the Omagari Area of Japan
- 1 June 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 17 (6) , 1053-1059
- https://doi.org/10.1161/01.atv.17.6.1053
Abstract
Low levels of HDL cholesterol have been clearly demonstrated to be associated with an increased incidence of coronary heart disease, strongly suggesting that HDL particles have an antiatherogenic function. However, little information has been available concerning the atherogenicity of a marked hyperalphalipoproteinemia (HALP). There is no agreement about whether plasma cholesteryl ester transfer protein (CETP) deficiency is associated with an antiatherogenic state or not, although this disorder was reported to be one of the major causes of marked HALP. In the current study, we have found a unique area (Omagari City, Akita Prefecture, Japan) where CETP deficiency caused by a G-to-A mutation at the 5′ splice donor site of intron 14 in the CETP gene is extremely frequent. In Omagari City, the mutation was detected more than 20 times more frequently and the prevalence of a marked HALP with plasma HDL cholesterol ≥2.58 mmol/L (100 mg/dL) was 5 to 10 times higher than in other areas of Japan. This disc...Keywords
This publication has 31 references indexed in Scilit:
- Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene.Journal of Clinical Investigation, 1995
- Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiencyEuropean Journal of Clinical Investigation, 1995
- A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins.Journal of Clinical Investigation, 1993
- Detection of a point mutation in cholesteryl ester transfer protein gene by polymerase chain reaction-mediated site-directed mutagenesisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- Probucol increases cholesteryl ester transfer protein activity in hypercholesterolaemic patientsEuropean Journal of Clinical Investigation, 1991
- Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transferThe American Journal of Cardiology, 1988
- Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activityAtherosclerosis, 1988
- Deletion in the Gene for the Low-Density-Lipoprotein Receptor in a Majority of French Canadians with Familial HypercholesterolemiaNew England Journal of Medicine, 1987
- Marked hyper-HDL2-cholesterolemia associated with premature corneal opacity: A case reportAtherosclerosis, 1984